Company research
Vyant Bio, Inc.
CIK 1349929Updated Nov 16, 2026
Securities
Historical securities (2)
VYNT · OTC · equity · closed Dec 29, 2023VYNT · OTC · equity · closed Dec 29, 2023Name history
CANCER GENETICS, INC · through Mar 31, 2021CANCER GENETICS INC · through Nov 1, 2010
VYNT price & chart
Historical security
This listing closed Dec 29, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 15,205,000Source | 37,636,000Source | 8,348,000Source | 14,904,000Source |
| Property, Plant and Equipment, NetUSD | 1,106,000Source | 1,020,000Source | 1,031,000Source | 558,000Source |
| GoodwillUSD | — | 2,164,000Source | 2,977,000Source | 3,090,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 0Source | 2,895,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,041,000Source | 20,608,000Source | 2,444,000Source | 3,880,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 779,000Source | 696,000Source |
| Inventory, NetUSD | 53,000Source | 475,000Source | — | — |
| Assets, CurrentUSD | 11,509,000Source | 23,214,000Source | 4,107,000Source | 7,178,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 747,000Source | 895,000Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 1,542,000Source | 673,000Source | 248,000Source | 94,000Source |
| Other Assets, NoncurrentUSD | — | — | 3,793,000Source | 7,168,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,296,000Source | 6,346,000Source | 4,368,000Source | 7,519,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,000Source | 3,000Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 111,443,000Source | 110,174,000Source | 176,628,000Source | 171,783,000Source |
| Retained Earnings (Accumulated Deficit)USD | -101,503,000Source | -78,813,000Source | -172,425,000Source | -164,424,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -32,000Source | -74,000Source | -223,000Source | 26,000Source |
| Stockholders' Equity Attributable to ParentUSD | 9,909,000Source | 31,290,000Source | 3,980,000Source | 7,385,000Source |
| Liabilities and EquityUSD | 15,205,000Source | 37,636,000Source | 8,348,000Source | 14,904,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,665,000Source | 5,431,000Source | 4,263,000Source | 6,972,000Source |
| Operating Lease, Liability, CurrentUSD | 313,000Source | 174,000Source | 223,000Source | 193,000Source |
| Accounts Payable, CurrentUSD | 655,000Source | 740,000Source | — | — |
| Operating Lease, Liability, NoncurrentUSD | 1,301,000Source | 516,000Source | 32,000Source | 10,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,154,000Source | 764,000Source | — | — |
| Deferred Revenue, CurrentUSD | 72,000Source | 74,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 57,000Source | 57,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 57,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,186,000Source | 1,003,000Source | 179,000Source | 263,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | 89,000Source | -81,000Source |
| Increase (Decrease) in InventoriesUSD | -422,000Source | 60,000Source | — | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -13,681,000Source | -16,993,000Source | -5,371,000Source | -8,660,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 3,263,000Source | 29,619,000Source | 1,013,000Source | 9,091,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 617,000Source | 535,000Source | 39,000Source | 28,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -149,000Source | 7,190,000Source | 2,640,000Source | 3,305,000Source |
| Repayments of Long-term DebtUSD | — | 82,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -10,567,000Source | 19,816,000Source | -1,786,000Source | 3,719,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 2,444,000Source | 4,230,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 34,000Source | 8,000Source | 11,000Source | 1,501,000Source |
| Income Taxes Paid, NetUSD | 8,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | -68,000Source | -17,000Source |
| Additional Financial Items | ||||
| Accretion ExpenseUSD | — | 173,000Source | — | — |
| Share-based Payment Arrangement, ExpenseUSD | 1,186,000Source | 1,003,000Source | 179,000Source | 263,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | 181,000Source | 497,000Source |
| Amortization of Intangible AssetsUSD | 0Source | 713Source | — | — |
| DepreciationUSD | 522,000Source | 550,000Source | 166,000Source | 159,000Source |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | -6,883,000Source | -22,284,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 42,000Source | 74,000Source | — | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | 167,000Source | 70,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -119,000Source | -256,000Source |
| General and Administrative ExpenseUSD | — | — | 6,595,000Source | 5,171,000Source |
| GoodwillUSD | — | 2,164,000Source | 2,977,000Source | 3,090,000Source |
| Goodwill, Impairment LossUSD | 2,164,000Source | 20,216,000Source | 0Source | 2,873,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | 2,201,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -8,043,000Source | -6,885,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -15,807,000Source | -18,575,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -6,883,000Source | -22,284,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | -512,000Source |
| Investment Income, InterestUSD | — | — | 0Source | 108,000Source |
| Net Income (Loss) Attributable to ParentUSD | -22,690,000Source | -40,859,000Source | -8,001,000Source | -6,708,000Source |
| Nonoperating Income (Expense)USD | 105,000Source | -2,869,000Source | 140,000Source | -1,694,000Source |
| Operating ExpensesUSD | 16,578,000Source | 16,854,000Source | 10,581,000Source | 9,307,000Source |
| Other Nonoperating Income (Expense)USD | 12,000Source | 57,000Source | 307,000Source | 59,000Source |
| Proceeds from Issuance of Common StockUSD | -188,000Source | 41,000Source | 3,074,000Source | 5,412,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | 973,000Source | — | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 666,000Source | 1,148,000Source | 5,751,000Source | 7,305,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -15,912,000Source | -15,706,000Source | -8,183,000Source | -5,703,000Source |
| Other Nonoperating Income (Expense)USD | 12,000Source | 57,000Source | 307,000Source | 59,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -15,807,000Source | -18,575,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | -512,000Source |
| Net Income (Loss) Attributable to ParentUSD | -22,690,000Source | -40,859,000Source | -8,001,000Source | -6,708,000Source |
| Earnings Per Share, BasicUSD per share | -3.87Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 5,868,000Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 5,868,402Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 0Source | 713Source | — | — |
| Business Combination, Acquisition Related CostsUSD | — | 2,310,000Source | 539,000Source | 117,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 522,000Source | 550,000Source | — | — |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of TaxUSD | -6,883,000Source | -22,284,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 42,000Source | 74,000Source | — | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | 167,000Source | 70,000Source |
| General and Administrative ExpenseUSD | — | — | 6,595,000Source | 5,171,000Source |
| Goodwill, Impairment LossUSD | 2,164,000Source | 20,216,000Source | 0Source | 2,873,000Source |
| Gross ProfitUSD | — | — | 2,398,000Source | 3,604,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -8,043,000Source | -6,885,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -15,807,000Source | -18,575,000Source | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -2.69Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -6,883,000Source | -22,284,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | 0Source |
| Interest ExpenseUSD | — | — | 272,000Source | 1,437,000Source |
| Interest Income (Expense), NetUSD | 93,000Source | -372,000Source | — | — |
| Investment Income, InterestUSD | — | — | 0Source | 108,000Source |
| Nonoperating Income (Expense)USD | 105,000Source | -2,869,000Source | 140,000Source | -1,694,000Source |
| Operating ExpensesUSD | 16,578,000Source | 16,854,000Source | 10,581,000Source | 9,307,000Source |
| Research and Development ExpenseUSD | 6,772,000Source | 4,273,000Source | — | 0Source |
| Selling and Marketing ExpenseUSD | 8,798,000Source | 8,424,000Source | 1,246,000Source | 1,146,000Source |